# US 2005/0240168 A1 · Multipurpose diode laser system for ophthalmic laser treatments

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0240168 A1
- Document ID: US20050240168A1
- Status: Published application
- Kind: A1
- Application number: 11/157,901
- Filed: 2005-06-17
- Published: 2005-10-27
- Earliest claimed: 2002-12-11
- Assignees: CeramOptec Industries, Inc.
- Inventors: Wolfgang Neuberger; Detlev Berndt; Julian Maughan
- Web page: https://patentgrep.com/patent/US20050240168A1

## CPC

- A61F 9/008: using laser
- A61F 9/00821: {for coagulation}
- A61F 2009/00863: {Retina}
- A61F 2009/00891: {Glaucoma}
- A61N 5/062: {Photodynamic therapy, i.e. excitation of an agent}
- A61N 5/067: using laser light
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A laser device and method for treating ophthalmic diseases is enclosed. The laser device and method for treating a variety of ophthalmic diseases comprises a system for irradiating the eye with electromagnetic irradiation with a wavelength in the range of 654-681 nm from at least one high power laser diode. The optical system of the present invention being able to focus the radiation onto a spot sized of about 100 μm. The system preferably comprises a laser source and ancillary equipment to direct and regulate the radiation. The use of this wavelength range makes the present invention effective for a wide variety of ophthalmic indications. It is capable of providing photocoagulation treatments for diseases such as glaucoma, diabetic retinopathy and age-related macular degeneration.

## Claims

### Claim 1

An ophthalmic laser treatment device for direct treatment of an eye's fundus comprising:
a laser radiation source emitting radiation having a wavelength of 668 nm +/− 20%;
means to direct and control said radiation to a treatment area in an eye; and
means to couple said radiation to said means to direct and control.

### Claim 2 (depends on 1)

The ophthalmic laser treatment device according to claim 1, wherein said radiation source is at least one high power diode laser.

### Claim 3 (depends on 2)

The ophthalmic laser treatment device according to claim 2, wherein said laser radiation source is said diode laser having a light diverging gain region selected from a group consisting of a trapezoidal shaped region and a “bow-tie” shaped region.

### Claim 4 (depends on 1)

The ophthalmic laser treatment device according to claim 1, wherein said coupling means is an optical fiber.

### Claim 5 (depends on 4)

The ophthalmic laser treatment device according to claim 4, wherein said optical fiber is an oligimode fiber.

### Claim 6 (depends on 4)

The ophthalmic laser treatment device according to claim 4, wherein a core of said optical fiber has a diameter not greater than 50 microns.

### Claim 7 (depends on 1)

The ophthalmic laser treatment device according to claim 1, wherein said means to direct and control is a slit lamp adaptor for outputting a laser beam having a treatment spot size of 100 μm or less into said eye's fundus.

### Claim 8

A method for ophthalmic laser treatment, comprising the steps of
determining treatment parameters;
directing radiation having a wavelength of 668 nm +/− 20% to an area of treatment of an eye using said determined treatment parameters, said radiation being output by at least one high power laser diode, said radiation being output to a spot of about 100 μm or less in the area of treatment; and
irradiating said treatment area of said eye with said radiation resulting in said treatment.

### Claim 9 (depends on 8)

The method according to claim 8, wherein said step of directing said radiation is accomplished by providing entry of said radiation to said treatment area transsclerally or transpupillarily.
